What is the Share Price of Krebs Biochemicals Industries Ltd?

Krebs Biochemicals Industries Ltd share price is ₹85.12 As on 17 November, 2024|20:59

Home
>
Stocks
>
Krebs Biochemicals Industries Ltd

Krebs Biochemicals Industries Ltd Share/Stock Price

Q: What is the Market Cap of Krebs Biochemicals Industries Ltd?

The Market Cap of Krebs Biochemicals Industries Ltd is ₹184 As on 17 November, 2024|20:59

Q: What is PE Ratio of Krebs Biochemicals Industries Ltd?

The P/E ratio of Krebs Biochemicals Industries Ltd is 0 As on 17 November, 2024|20:59

Q: What is PB Ratio of Krebs Biochemicals Industries Ltd?

The PB ratio of Krebs Biochemicals Industries Ltd is -1.41 As on 17 November, 2024|20:59

₹ 85.12 -0.06 (-0.07%)
Updated on 14-11-2024 4:40 PM

Stock Rating

Pros 0

Cons 7

Krebs Biochemicals Industries Ltd Price Performance

Day's Low
₹83.11

Day's High
₹89.67

₹ 85.12

52-w low
₹60.35

52-w high
₹121.55

85.12

Day's open
₹88
Previous close
₹85.18
VWAP
₹86.15
Lower price band
₹68.09
Upper price band
₹102.14

Today's Market Action

The last traded share price of Krebs Biochemicals Industries Ltd was 85.12 down by -0.07% on the NSE. Its last traded stock price on BSE was 85.63 up by 1.88%. The total volume of shares on NSE and BSE combined was 26,771 shares. Its total combined turnover was Rs 0.23 crores.

Krebs Biochemicals Industries Ltd Medium and Long Term Market Action

Krebs Biochemicals Industries Ltd hit a 52-week high of 121.55 on 19-07-2024 and a 52-week low of 60.35 on 28-03-2024. The stock price of Krebs Biochemicals Industries Ltd is up by 4% over the last one month. It is up by 1.09% over the last one year. Don't forget to check the full stock price history in the table below.

Krebs Biochemicals Industries Ltd Fundamentals

Market Cap (Cr): 184
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Krebs Biochemicals Industries Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Krebs Biochemicals Industries Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Krebs Biochemicals Industries Ltd

Data not available.

Krebs Biochemicals Industries Ltd FAQ's

What is Share Price of Krebs Biochemicals Industries Ltd?

What is the Market Cap of Krebs Biochemicals Industries Ltd?

What is PE Ratio of Krebs Biochemicals Industries Ltd?

What is PB Ratio of Krebs Biochemicals Industries Ltd?

What is the CAGR of Krebs Biochemicals Industries Ltd?

How to Buy Krebs Biochemicals Industries Ltd Share?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

No Data Available

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only -25.00% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Negative operating earnings and interest coverage
The company has a negative operating earnings and a negative Interest coverage ratio of -1.80 times which implies that the company has no operating earnings to pay for interest which is currently being paid out of capital and/or other income. This is extremely negative for shareholders.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.33. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Negative Equity
The company has a negative debt to equity ratio of -1.58. This implies that the underlying equity value of the business is 0 and the networth of equity holders is negative. For all practical purposes, this business is owned by it's debt holders leaving nothing for the equity holders.

Valuation Analysis

Margin of safety
(17/11/2024)

Margin of Safety Index: High

0% People are bullish about Krebs Biochemicals Industries Ltd

0 % People are bearish about Krebs Biochemicals Industries Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %